Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""head and neck neoplasms"" wg kryterium: Temat


Tytuł:
Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study.
Autorzy:
Guan Z; Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Liu J; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, NO.1 Jianshedong Road, Zhengzhou, 450052, Henan, China.
Zheng L; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, NO.1 Jianshedong Road, Zhengzhou, 450052, Henan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 15; Vol. 14 (1), pp. 6304. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/radiotherapy
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/radiotherapy
Mouth Neoplasms*/genetics
Mouth Neoplasms*/radiotherapy
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Glucose
Czasopismo naukowe
Tytuł:
Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer.
Autorzy:
Yang F; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Yuan C; Department of Biostatistics and Bioinformatics, Rolling School of Public Health, Emory University, Atlanta, GA, 30322, USA.
Chen F; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Qin ZS; Department of Biostatistics and Bioinformatics, Rolling School of Public Health, Emory University, Atlanta, GA, 30322, USA.
Schmitt NC; Department of Otolaryngology, Emory University, Atlanta, GA, 30322, USA.
Lesinski GB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Teng Y; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA. .; Department of Oral Biology and Diagnostic Sciences, Georgia Cancer Center, Augusta University, Augusta, GA, 30912, USA. .; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30322, USA. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 12; Vol. 43 (1), pp. 76. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Papillomavirus Infections*/complications
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/metabolism
Animals ; Mice ; Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/metabolism ; Interleukin-6/metabolism ; Neoplasm Recurrence, Local/metabolism ; Killer Cells, Natural ; Receptors, CCR2/genetics ; Receptors, CCR2/metabolism
Czasopismo naukowe
Tytuł:
Successful microvascular surgery in patients with thrombophilia in head and neck surgery: a case series.
Autorzy:
Faber J; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Cologne, 50937, Cologne, Germany. .
Schuster F; Department of Anaesthesia and Critical Care, Donau-Isar-Klinikum, 94469, Deggendorf, Germany.
Hartmann S; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Brands RC; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Fuchs A; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Straub A; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Fischer M; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Müller-Richter U; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Linz C; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Cologne, 50937, Cologne, Germany.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Feb 28; Vol. 18 (1), pp. 119. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Free Tissue Flaps*/blood supply
Thrombophilia*/complications
Thrombophilia*/drug therapy
Thrombosis*/etiology
Head and Neck Neoplasms*/complications
Head and Neck Neoplasms*/surgery
Humans ; Male ; Retrospective Studies ; Postoperative Complications ; Anticoagulants/therapeutic use
Czasopismo naukowe
Tytuł:
Prognostic model for overall survival of head and neck cancer patients in the palliative phase.
Autorzy:
Hoesseini A; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands. .
Sewnaik A; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
van den Besselaar BN; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Zhang J; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
van Leeuwen N; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
Hardillo JA; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Baatenburg de Jong RJ; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Offerman MPJ; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Pokaż więcej
Źródło:
BMC palliative care [BMC Palliat Care] 2024 Feb 24; Vol. 23 (1), pp. 54. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*
Head and Neck Neoplasms*/complications
Head and Neck Neoplasms*/therapy
Humans ; Squamous Cell Carcinoma of Head and Neck/therapy ; Prognosis ; Proportional Hazards Models
Czasopismo naukowe
Tytuł:
Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment.
Autorzy:
Ding Q; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Lin F; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Huang Z; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Li Y; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Cai S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Chen X; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Liu H; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China. .; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China. .
Qiu S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China. .; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 23; Vol. 14 (1), pp. 4426. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Cell Adhesion Molecules*/genetics
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
MicroRNAs*/genetics
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Humans ; Biomarkers ; Down-Regulation ; Prognosis ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł:
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome.
Autorzy:
Broghammer F; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Korovina I; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany.
Gouda M; Department of Otorhinolaryngology, Head and Neck Surgery, Ludwigs-Maximilians-University University Hospital, 81377, Munich, Germany.
Celotti M; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, 3584 CT, Utrecht, the Netherlands.
van Es J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, 3584 CT, Utrecht, the Netherlands.
Lange I; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Brunner C; Department of Otorhinolaryngology, Ulm University Medical Center, 89075, Ulm, Germany.
Mircetic J; German Cancer Consortium, Partner Site Dresden: German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Mildred Scheel Early Career Center (MSNZ) P2, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Coppes RP; Department of Biomedical Sciences of Cells and Systems, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, 9713, Groningen, The Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, 9713, Groningen, The Netherlands.
Gires O; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany.
Dahl A; DRESDEN-Concept Genome Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Dresden, Germany.
Seifert M; Institute for Medical Informatics and Biometry (IMB), Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), 69192, Heidelberg, Germany.
Cordes N; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany. .; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany. .; German Cancer Consortium, Partner Site Dresden: German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. .; National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), 69192, Heidelberg, Germany. .; Department of Radiotherapy and Radiation Oncology, University Hospital Carl Gustav Carus, 01307, Dresden, Germany. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Feb 21; Vol. 23 (1), pp. 39. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Antineoplastic Agents*/therapeutic use
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Integrin beta1/genetics ; Cell Line, Tumor ; Receptor Protein-Tyrosine Kinases/genetics ; ErbB Receptors/metabolism ; Phenotype ; Epithelial-Mesenchymal Transition/genetics
Czasopismo naukowe
Tytuł:
The association of HBV infection and head and neck cancer: a systematic review and meta-analysis.
Autorzy:
Tan R; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Zhu X; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Sun Y; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Yang S; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Peng C; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Feng X; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Chen Z; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Yimamu Y; The First People's Hospital of Kashi Area, Xinjiang Uygur Autonomous Region, No.120, Yingbin Avenue, Kashi, People's Republic of China.
Liao G; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China. .; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China. .
Yang L; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China. .; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 16; Vol. 24 (1), pp. 225. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Hepatitis B*/complications
Hepatitis B*/epidemiology
Head and Neck Neoplasms*/etiology
Head and Neck Neoplasms*/complications
Nasopharyngeal Neoplasms*/complications
Mouth Neoplasms*
Humans ; Hepatitis B virus ; Cohort Studies ; Nasopharyngeal Carcinoma/complications
Czasopismo naukowe
Tytuł:
CTC together with Shh and Nrf2 are prospective diagnostic markers for HNSCC.
Autorzy:
Rahman MM; Rangamati Medical College, Rangamati, Bangladesh.; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Hossain MM; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh. .; EuGEF Research Foundation, Chattogram, Bangladesh. .
Islam S; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.; Present Address: Stem Cell Genetics, Institute of Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Ahmed R; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Majumder M; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Dey S; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Kawser M; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Sarkar B; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Himu MER; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Chowdhury AA; Department of Radiotherapy, Chittagong Medical College, Chattogram, Bangladesh.
Ahmed S; Department of Surgery, Chittagong Medical College, Chattogram, Bangladesh.
Biswas S; Department of Otolaryngology and Head Neck Surgery, Chittagong Medical College, Chattogram, Bangladesh.
Anwar MM; Department of Otolaryngology and Head Neck Surgery, Chittagong Medical College, Chattogram, Bangladesh.
Hussain MJ; Department of Otolaryngology and Head Neck Surgery, Rangamati Medical College, Rangamati, Bangladesh.
Kumar Shil R; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Baidya S; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Parial R; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Islam MM; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Bharde A; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Jayant S; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Aland G; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Khandare J; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Uddin SB; Department of Botany, University of Chittagong, Chattogram, Bangladesh.
Noman ASM; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh. .; EuGEF Research Foundation, Chattogram, Bangladesh. .
Pokaż więcej
Źródło:
BMC molecular and cell biology [BMC Mol Cell Biol] 2024 Feb 10; Vol. 25 (1), pp. 4. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Journal Article
MeSH Terms:
NF-E2-Related Factor 2*
Head and Neck Neoplasms*/diagnosis
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/diagnosis ; Squamous Cell Carcinoma of Head and Neck/genetics ; Prospective Studies ; Hedgehog Proteins
Czasopismo naukowe
Tytuł:
Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma.
Autorzy:
Huang Y; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Liu H; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Liu B; Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, China.
Chen X; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Li D; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Xue J; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Li N; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Zhu L; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Yang L; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Xiao J; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China. .; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China. .
Liu C; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China. .; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China. .
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2024 Feb 08; Vol. 17 (1), pp. 49. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/therapy
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/therapy ; Mutation ; Prognosis ; Biomarkers, Tumor/genetics ; Immunotherapy ; Epithelial-Mesenchymal Transition/genetics
Czasopismo naukowe
Tytuł:
Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells.
Autorzy:
Klieber N; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Hildebrand LS; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Faulhaber E; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Symank J; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Häck N; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Härtl A; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Fietkau R; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Distel LV; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 06; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/radiotherapy
Papillomavirus Infections*
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Apoptosis ; Cell Line, Tumor ; G2 Phase Cell Cycle Checkpoints ; TOR Serine-Threonine Kinases/metabolism ; Radiation, Ionizing
Czasopismo naukowe
Tytuł:
Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis.
Autorzy:
Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Sánchez-Canteli M; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain. .; Department of Otolaryngology, Hospital Universitario de Cabueñes and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011, Oviedo, Spain. .
Otero-Rosales M; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Martínez-Camblor P; Department of Anesthesiology, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.; Faculty of Health Sciences, Universidad Autonoma de Chile, 7500912, Providencia, Chile.
Hermida-Prado F; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
García-Pedrero JM; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Feb 04; Vol. 22 (1), pp. 135. Date of Electronic Publication: 2024 Feb 04.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Immunotherapy*/methods
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Prognosis ; Survival Analysis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/analysis ; Mutation/genetics
Czasopismo naukowe
Tytuł:
Evaluating the effects of lymphoedema management strategies on functional status and health-related quality of life following treatment for head and neck cancer: Protocol for a systematic review.
Autorzy:
Mullan LJ; School of Nursing, Institute of Nursing and Health Research, Ulster University, Belfast, United Kingdom.
Blackburn NE; School of Health Sciences, Institute of Nursing and Health Research, Ulster University, Londonderry, United Kingdom.
Lorimer J; Physiotherapy Department, Cancer Centre, Belfast Health and Social Care Trust, Belfast, United Kingdom.
Semple CJ; School of Nursing, Institute of Nursing and Health Research, Ulster University, Belfast, United Kingdom.; Cancer Services, South Eastern Health and Social Care Trust, Belfast, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 02; Vol. 19 (2), pp. e0297757. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Quality of Life*
Head and Neck Neoplasms*/complications
Head and Neck Neoplasms*/therapy
Adult ; Humans ; Functional Status ; Research Design ; Systematic Reviews as Topic ; Meta-Analysis as Topic
Czasopismo naukowe
Tytuł:
Cocaine use and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
Autorzy:
Zhang M; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA.
Chen C; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Li G; Department of Head and Neck Surgery, Division of Surgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Koric A; Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, and Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Lee YA; Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, and Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Morgenstern H; Departments of Epidemiology and Environmental Health Sciences, School of Public Health and Department of Urology, Medical School, University of Michigan, Ann Arbor, Michigan, USA.
Schwartz SM; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.
Boffetta P; Stony Brook Cancer Center, Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, New York, USA.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Hashibe M; Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, and Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Zhang ZF; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e7019.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Head and Neck Neoplasms*/epidemiology
Head and Neck Neoplasms*/etiology
Cocaine*
Humans ; Risk Factors ; Smoking/epidemiology ; Alcohol Drinking/adverse effects ; Alcohol Drinking/epidemiology ; Case-Control Studies
Czasopismo naukowe
Tytuł:
Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer.
Autorzy:
Mellor R; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, Australia.
Girgis CM; Department of Diabetes and Endocrinology, Westmead Hospital, Westmead, NSW 2145, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.
Rodrigues A; The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW 2010, Australia.
Chen C; Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW 2148, Australia.
Cuan S; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, Australia.
Gambhir P; Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW 2148, Australia.
Perera L; Nepean Cancer Care Centre, Nepean Hospital, Kingswood, NSW 2747, Australia.
Veness M; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.
Sundaresan P; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.; Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW 2148, Australia.
Gao B; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.; Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW 2148, Australia.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 01; Vol. 31 (2), pp. 828-838. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Nasopharyngeal Neoplasms*
Diabetes Mellitus, Type 2*/complications
Head and Neck Neoplasms*/therapy
Head and Neck Neoplasms*/etiology
Diabetes Complications*/etiology
Insulins*
Humans ; Retrospective Studies ; Case-Control Studies ; Chemoradiotherapy/adverse effects
Czasopismo naukowe
Tytuł:
Erythrocyte PIG-A mutant frequencies in cancer patients receiving cisplatin.
Autorzy:
Dobrovolsky VN; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Jefferson, Arkansas, USA.
Atiq OT; University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas, USA.
Heflich RH; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Jefferson, Arkansas, USA.
Maisha M; Office of Scientific Coordination, NCTR, FDA, Jefferson, Arkansas, USA.
McKinzie PB; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Jefferson, Arkansas, USA.
Pearce MG; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Jefferson, Arkansas, USA.
Robison TW; Office of New Drugs, OII, DPTII, Center for Drug Evaluation and Research (CDER), US FDA, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6895. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms, Second Primary*
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Cisplatin/adverse effects ; Erythrocytes ; Mutagenesis
Czasopismo naukowe
Tytuł:
Towards effectiveness of cell free DNA based liquid biopsy in head and neck squamous cell carcinoma.
Autorzy:
Kowal-Wisniewska E; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland. .; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland. .
Jaskiewicz K; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
Bartochowska A; Department of Otolaryngology and Laryngeal Oncology, Poznan University of Medical Sciences, Poznan, Poland.
Kiwerska K; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.; Department of Tumor Pathology, Greater Poland Cancer Centre, Poznan, Poland.
Ustaszewski A; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
Gorecki T; Faculty of Mathematics and Computer Science, Adam Mickiewicz University, Poznan, Poland.
Giefing M; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
Paluszczak J; Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Poznan, Poland.
Wierzbicka M; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.; Department of Otolaryngology and Laryngeal Oncology, Poznan University of Medical Sciences, Poznan, Poland.; Faculty of Medicine Wroclaw, University of Science and Technology, Wroclaw, Poland.
Jarmuz-Szymczak M; Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 26; Vol. 14 (1), pp. 2251. Date of Electronic Publication: 2024 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Cell-Free Nucleic Acids*/genetics
Head and Neck Neoplasms*/diagnosis
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/surgery
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/surgery ; Liquid Biopsy ; Specimen Handling ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
Development and validation of survival prognostic models for head and neck cancer patients using machine learning and dosiomics and CT radiomics features: a multicentric study.
Autorzy:
Mansouri Z; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland.
Salimi Y; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland.
Amini M; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland.
Hajianfar G; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland.
Oveisi M; Department of Computer Science, University of British Columbia, Vancouver, BC, Canada.
Shiri I; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland.
Zaidi H; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland. .; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. .; Department of Nuclear Medicine, University of Southern Denmark, Odense, Denmark. .; University Research and Innovation Center, Óbuda University, Budapest, Hungary. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2024 Jan 22; Vol. 19 (1), pp. 12. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Radiomics*
Head and Neck Neoplasms*/diagnostic imaging
Head and Neck Neoplasms*/radiotherapy
Humans ; Prognosis ; Machine Learning ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
An ESR1-Related Gene Signature Identifies Head and Neck Squamous Cell Carcinoma with Imputed Susceptibility to Endocrine Therapy.
Autorzy:
Almouhanna F; Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Hess J; Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Research Group Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 19; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Quality of Life
Czasopismo naukowe
Tytuł:
Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors.
Autorzy:
Wang C; Department of Radiation Oncology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Hou Y; Department of Radiation Oncology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Wang L; Department of Radiation Oncology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Yang Y; Department of Radiation Oncology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Li X; Department of Radiation Oncology, The First Hospital of Shanxi Medical University, Taiyuan, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 5. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/epidemiology
Head and Neck Neoplasms*/radiotherapy
Head and Neck Neoplasms*/complications
Hypothyroidism*/epidemiology
Hypothyroidism*/etiology
Humans ; Radiotherapy Dosage ; Risk Factors
Czasopismo naukowe
Tytuł:
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial.
Autorzy:
Kim KH; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Lim SM; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Ahn HK; Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Kim HR; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Lee HW; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea.
An HJ; Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Kim JS; Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 37-47. Date of Electronic Publication: 2023 Jul 20.
Typ publikacji:
Clinical Trial, Phase II; Multicenter Study; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/genetics
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Indoles*
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Precision Medicine ; Antineoplastic Combined Chemotherapy Protocols
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies